Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons B.T. Santema

Publicaties

Clinical and Proteomic Risk Profiles of New-Onset Heart Failure in Men and Women

Clinical Presentation, Biomarker Trajectories, and Outcomes in Women and Men Hospitalized for Acute Heart Failure

Up-titration of medication in patients with new-onset heart failure with and without atrial fibrillation

Achieved dose and treatment discontinuation of candesartan in men and women with chronic heart failure: data from CHARM

Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: Data from the AF-RISK study

Distinct pathophysiological pathways in women and men with heart failure

Pathophysiological pathways in patients with heart failure and atrial fibrillation

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Differences in biomarkers and molecular pathways according to age for patients with HFrEF

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction

Pers/media

Dit is waarom mannen en vrouwen anders reageren op dezelfde medicijnen